NEW YORK (GenomeWeb) – Hologic reported after the close of the market on Wednesday that its fiscal second quarter revenues grew 5 percent year over year as its molecular diagnostic revenues grew more than 6 percent. 

For the three months ended March 28 the Bedford, Mass.-based firm said that it recorded total revenues of $655.5, up from $625 million in the year-ago quarter. It beat the average analysts' estimate of $645.6 million. 

On a constant currency basis, revenues were up 7 percent, Hologic said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.